Sep 12, 2024 | 09:00 AM BST | seqera

Seqera Sessions, Cambridge, UK

Join us at Seqera Sessions to learn how to scale your bioinformatics workflows and accelerate the entire analysis lifecycle, from data generation to actionable insights.

Seqera Sessions, Cambridge, UK

About

Why attend?

  • Hands-on Nextflow training: Design your first bioinformatics workflow and create workflow endpoints for automatic analysis on Seqera.
  • Industry-led sessions: Hear the latest real-world genomic analysis research stories from leading innovators.
  • Live demos: Launch and monitor workflows at scale on Seqera's cloud environment.
  • Expert insights and networking: Stay updated on the latest advancements in bioinformatics and meet the pioneers.

Event information

Morning: Nextflow Training

Dive into the Nextflow language and build your first bioinformatics workflow in just 3 hours! You'll receive a Certificate of attendance and exclusive Seqera Swag.

Space is limited, so register early to secure your spot and level up your bioinformatics skills.

Nextflow training attendees will be asked a minimal fee to cover training costs.

Afternoon: Seqera Sessions

Free entry from 2:30 PM. Advance registration is required.

Clayton Hotel, Cambridge

Agenda

09:00 AM

Training: Arrival & Registrations and set-up time

09:15 AM

Nextflow Fundamentals Training

1:30 PM

Lunch for Training attendees

2:30 PM

Sessions: Arrivals & Registrations

3:00 PM

Seqera Presentation and Demo: Evan Floden, CEO & Co-founder, Seqera

3:20 PM

Industry presentation with Peter Saffrey, Director of Bioinformatics and Software Engineering at biomodal

3:40 PM

Roundtable followed by Q&A with Ryvu, AstraZeneca, Biomodal and Seqera

4:05 PM

Networking over drinks/small bites

5:30 PM

End

Speakers

Miika Ahdesmäki

Miika Ahdesmäki

CIO at Ryvu, a clinical stage biopharmaceutical company developing therapeutics addressing clinical limitations of current treatments in oncology.

Manasa Surakala

Manasa Surakala

Associate Director, Omics Product Lead at AstraZeneca, a global, science-led biopharmaceutical business whose innovative medicines are used by millions of patients worldwide.

Peter Saffrey

Peter Saffrey

Director of Bioinformatics and Software Engineering at biomodal, a company that builds technologies and analytics as research tools for life scientists & clinical developers, by providing insight into the complexity and dynamism of cellular interactions.

Evan Floden

Evan Floden

CEO & Co-founder at Seqera, a company empowering scientists to solve today's most complex and essential challenges; from pioneering innovative therapeutics to unveiling the secrets of our universe.